Skip to main content
. Author manuscript; available in PMC: 2023 Jun 26.
Published in final edited form as: Vaccine. 2014 Feb 13;32(16):1798–1807. doi: 10.1016/j.vaccine.2014.01.089

Fig. 1.

Fig. 1.

Reported measles cases*, estimated coverage** with the routine first dose of measles-containing vaccine (MCV1), and measles supplemental immunization activities*** (SIAs), seven southern African countries, 1996–2011.

*Measles cases reported annually to WHO by member states through the WHO/UNICEF Joint Reporting Form.

**Population-weighted average using United Nations Development Programme population estimates and annual national WHO/UNICEF MCV1 coverage estimates for children aged 1 year for 1996–2011

***In each country, measles SIAs started with an initial catch-up SIA targeting all children aged 9 months to 14 years and then periodic follow-up SIAs, generally targeting all children born since the last SIA, conducted nationwide every 2–4 years targeting children aged 9–59 months, in some cases, expanded age groups were used in follow-up SIAs.